https://carrerasresearch.org/ca/publicacions/real-world-analysis-of-main-clinical-outcomes-in-patients-with-polycythemia-vera-treated-with-ruxolitinib-or-best-available-therapy-after-developing-resistanceintolerance-to-hydroxyurea/